significant drug interaction (P769): Difference between revisions
imported>Nzechimere (Added [ig] description: Mmekọrịta dị ịrịba ama na ụlọ ọgwụ n'etiti ihe abụọ na-arụ ọrụ ọgwụ na-emepụta ọgwụ (ya bụ, ọgwụ na / ma ọ bụ metabolites na-arụ ọrụ) ebe oriri concomitant nwere ike iduga ngbanwe nke ọma ma ọ bụ ọgwụ ọjọọ ev.) |
(No difference)
|
Latest revision as of 11:57, 4 August 2022
clinically significant interaction between two pharmacologically active substances (i.e., drugs and/or active metabolites) where concomitant intake can lead to altered effectiveness or adverse drug events. English
| Language | Label | Description | Also known as |
|---|---|---|---|
| British English | No label defined |
No description defined |
Data type
Item
Statements
Q19887775 (Deleted Item)
0 references
Q718753 (Deleted Item)
0 references
property usage tracking category English
Q26249998 (Deleted Item)
0 references
property proposal discussion English
source website for the property English
Q53869507 (Deleted Item)
constraint status English
Q21502408 (Deleted Item)
property scope English
Q54828448 (Deleted Item)
0 references